← All companies

RGEN Repligen Corp

BIOLOGICAL PRODUCTS, (NO DIAGNOSTIC SUBSTANCES) · $9.9B market cap · updated 2026-10-07
Market price
$174.86
Avg intrinsic value
$0.00
Margin of safety
—

Three independent discounted-cash-flow-style models value Repligen Corp every trading day. 0 of 3 currently price RGEN above its market price.

Model estimates

Free Cash Flow model$-24.12
Excess Profit model$-5.12
Residual Earnings model$-2.21
Dividend Discount model—

Quality snapshot

Piotroski F-Score7 / 9
Return on invested capital+1.6%
Net debt / EBITDA-0.4×
Gross margin+52.3%
Revenue CAGR-2.7%
Cash conversion2.4×
Dividend yield—
Buyback yield-0.5%

Run your own numbers

These are StockKitty's default assumptions. In the app, the models recompute live as you adjust growth, discount rates, and margins — and the AI explains the bull case, bear case, and quality picture.

Open RGEN in StockKitty

Same sector